Gujarat Themis Biosyn: Investor Call Recording Available Online
Gujarat Themis Biosyn Limited has made the call recordings of its investor/analyst conference call, held on August 10, 2026, available on its website. The company provided a link to access the audio recordings as per SEBI regulations.
This is a standard disclosure and does not provide new financial information or strategic updates that would significantly impact the company's stock price.
The announcement is a routine disclosure of investor call recordings and does not contain any material positive or negative financial information.
Gujarat Themis Biosyn Limited has submitted the call recordings of the investor/analyst conference call held on Monday, August 10, 2026, at 2:30 PM IST. The recordings are now available on the company's official website. This disclosure is made pursuant to Regulation 30 and Regulation 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided a direct link for accessing the audio call recording of the investors/analysts call.
The conference call took place on August 10, 2026. The company secretary and compliance officer, Vineet Gawankar, has informed the stock exchanges about the availability of these recordings.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.